Meysam Abolmaali Selected Research

Gam-COVID-Vac vaccine

1/2022

Severe Persistent Eczema in a Recipient of the Gam-COVID-Vac vaccine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Meysam Abolmaali Research Topics

Disease

3	COVID-19 01/2022 - 05/2021
1	Cerebral Hemorrhage 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Eczema 01/2022
1	Intervertebral Disc Displacement (Herniated Disc) 12/2021
1	Pain (Aches) 12/2021
1	Low Back Pain (Lumbago) 12/2021
1	Breast Neoplasms (Breast Cancer) 07/2021
1	Neoplasms (Cancer) 07/2021
1	Infections 05/2021
1	Venous Thrombosis (Deep-Vein Thrombosis) 02/2021
1	Hemorrhage 02/2021

Drug/Important Bio-Agent (IBA)

1	Hemostatics (Antihemorrhagics)IBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	Gam-COVID-Vac vaccineIBA 01/2022
1	VaccinesIBA 01/2022
1	Nicotinamide PhosphoribosyltransferaseIBA 07/2021
1	NAD (NADH)IBA 07/2021
1	MicroRNAs (MicroRNA)IBA 07/2021
1	Rituximab (Mabthera)FDA Link 05/2021
1	Warfarin (Coumadin)FDA LinkGeneric 02/2021
1	AnticoagulantsIBA 02/2021
1	RivaroxabanIBA 02/2021
1	Vitamin K FDA Link 02/2021

Therapy/Procedure

1	Cesarean Section (Caesarean Section) 01/2022
1	Diskectomy (Discectomy) 12/2021
1	Therapeutics 05/2021